Phase I study of TTC-352 in patients with estrogen receptor-positive metastatic breast cancer

被引：1

作者：

ORegan, Ruth M. ^{[1
]}

Hurley, Randolph ^{[2
]}

Sachdev, Jasgit C. ^{[3
]}

Bleeker, Jonathan ^{[4
]}

Tonetti, Debra ^{[5
]}

Thatcher, Gregory ^{[5
]}

Venuti, Robert ^{[5
]}

Dudek, Arkadiusz Z. ^{[5
]}

机构：

[1] Univ Wisconsin, Madison, WI USA

[2] HealthPartners Reg Canc Care Ctr, Minneapolis, MN USA

[3] HonorHlth Res Inst TGen, Scottsdale, AZ USA

[4] Sanford Hlth, Sioux Falls, SD USA

[5] TTC Oncol, Minneapolis, MN USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-CT051

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT051

引用

页数：2

共 50 条

[41] Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
Li, Weimin
O'Shaughnessy, Joyce
Hayes, Daniel
Campone, Mario
Bondarenko, Igor
Zbarskaya, Irina
Brain, Etienne
Stenina, Marina
Ivanova, Olga
Graas, Marie-Pascale
Neven, Patrick
Ricci, Deborah
Griffin, Thomas
Kheoh, Thian
Yu, Margaret
Gormley, Michael
Martin, Jason
Schaffer, Michael
Zelinsky, Kathy
De Porre, Peter
Johnston, Stephen R. D.
CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6002 - 6009
[42] Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study
Didembourg, Marie
Reda, Sara
Oldenburg, Johannes
Ruehl, Heiko
Douxfils, Jonathan
Morimont, Laure
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 546 - 554
[43] A phase I study of BKM120 and fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer
Ma, C. X.
Wang, J.
Luo, J.
Naughton, M.
Nagaraj, G.
Bazzell, N.
Ellis, M. J.
CANCER RESEARCH, 2013, 73
[44] A phase I study of BKM120 and fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer
Ma, Cynthia X.
Luo, Jingqin
Naughton, Michael
Ademuyiwa, Foluso
Suresh, Rama
Pluard, Timothy
Nagaraj, Gayathri
Arnold, Kaitlin
Lockhart, Craig
Ellis, Matthew J.
CANCER RESEARCH, 2015, 75
[45] Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: A Randomized Phase II Study
Osborne, C. Kent
Neven, Patrick
Dirix, Luc Y.
Mackey, John R.
Robert, Jean
Underhill, Craig
Schiff, Rachel
Gutierrez, Carolina
Migliaccio, Ilenia
Anagnostou, Valsamo K.
Rimm, David L.
Magill, Patrick
Sellers, Mark
CLINICAL CANCER RESEARCH, 2011, 17 (05) : 1147 - 1159
[46] Progesterone receptor signaling in estrogen receptor-positive breast cancer.
Young, Amy
Guan, Jane
Daemen, Anneleen
Friedman, Lori
Lin, Kui
MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 81 - 81
[47] The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
Hickey, Theresa E.
Selth, Luke A.
Chia, Kee Ming
Laven-Law, Geraldine
Milioli, Heloisa H.
Roden, Daniel
Jindal, Shalini
Hui, Mun
Finlay-Schultz, Jessica
Ebrahimie, Esmaeil
Birrell, Stephen N.
Stelloo, Suzan
Iggo, Richard
Alexandrou, Sarah
Caldon, C. Elizabeth
Abdel-Fatah, Tarek M.
Ellis, Ian O.
Zwart, Wilbert
Palmieri, Carlo
Sartorius, Carol A.
Swarbrick, Alex
Lim, Elgene
Carroll, Jason S.
Tilley, Wayne D.
NATURE MEDICINE, 2021, 27 (02) : 310 - +
[48] Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Morikawa, Aki
Henry, N. Lynn
CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3591 - 3596
[49] Estrogen receptor β- an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?
Maehle, Bjorn O.
Collett, Karin
Tretli, Steinar
Akslen, Lars A.
Grotmol, Tom
APMIS, 2009, 117 (09) : 644 - 650
[50] Factors Associated With Node-positive Disease in Estrogen Receptor-Positive Breast Cancer Patients
Gallagher, Julia
Elleson, Kelly M.
Englander, Katherine
Chintapally, Neha
Sun, Weihong
Whiting, Junmin
Laronga, Christine
Lee, Marie Catherine
JOURNAL OF SURGICAL RESEARCH, 2024, 295 : 327 - 331

← 1 2 3 4 5 →